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The development of distinct dendritic cell (DC) sub-
sets is regulated by cytokines. The ligand for the
FMS-like tyrosine kinase 3 receptor (Flt3L) is neces-
sary for plasmacytoid DC (pDC) and conventional
DC (cDC) maturation. The cytokine GM-CSF inhibits
Flt3L-driven pDC production while promoting cDC
growth. We show that GM-CSF selectively utilized its
signal transducer STAT5 to block Flt3L-dependent
pDC development from the lineage-negative, Flt3+
(lin Flt3+) bone-marrow subset. The signaling mole-
cule STAT3, by contrast, was necessary for expan-
sion of DC progenitors but not pDC maturation. In
vivo, STAT5 suppressed pDC formation during repo-
pulation of the DC compartment after bone-marrow
ablation. GM-CSF-dependent STAT5 signaling rap-
idly extinguished pDC-related gene expression in
lin Flt3+ progenitors. Inspection of the Irf8 promoter
revealed that STAT5 was recruited during GM-CSF-
mediated suppression, indicating that STAT5 directly
inhibited transcription of this critical pDC gene. Our
results therefore show that GM-CSF controls the pro-
duction of pDCs by employing STAT5 to suppress
IRF8 and the pDC transcriptional network in lin
Flt3+ progenitors.
INTRODUCTION
Dendritic cells (DCs) provide a critical link between the innate and
adaptive immune systems by sensing foreign- and host-derived
antigens and inducing lymphocyte activation or tolerance. DC
subsets are distinguished phenotypically by cell-surface markers
and functionally by antigen-presentation capabilities and cyto-
kine-secretion patterns (Banchereau and Steinman, 1998; Short-
man and Liu, 2002). Plasmacytoid DCs (pDCs) are a specialized
lineage and serve as the professional interferon (IFN)-producing
cells of the immune system (Asselin-Paturel et al., 2001; Cella
et al., 1999; Nakano et al., 2001; Siegal et al., 1999). In response
to infection, pDCs produce massive quantities of type I IFN and
then undergo maturation to an antigen-presenting form (Kado-
waki et al., 2000; Liu, 2005). pDCs are therefore consideredto have an important role in establishing antiviral immunity and
shaping the outcome of immune responses.
DCs arise from hematopoietic stem cells in the bone marrow,
with DC developmental potential restricted at the progenitor
stage to the lineage-negative, FMS-like tyrosine kinase 3 recep-
tor-positive (lin Flt3+) subset (D’Amico and Wu, 2003; Karsunky
et al., 2003). pDCs and conventional DCs (cDCs) share a com-
mon precursor within the lin Flt3+ compartment (Naik et al.,
2007; Onai et al., 2007). The common DC precursor expresses
granulocyte-macrophage colony-stimulating factor receptor al-
pha (GM-CSFRa) and transcription factors associated with DC
development (Onai et al., 2007). Flt3 ligand (Flt3L) is necessary
for steady-state DC production (McKenna et al., 2000). Adminis-
tration of exogenous Flt3L enhances DC production and stimu-
lates DC mobilization (Karsunky et al., 2003; Maraskovsky
et al., 1996; Pulendran et al., 2000). Flt3L signaling via its recep-
tor Flt3 has instructive activity, modifying the developmental
potential of Flt3 hematopoietic progenitors and Flt3 megakar-
yocyte-erythroid progenitors (MEPs) to produce pDCs and cDCs
(Onai et al., 2006). The STAT3 transcription factor is crucial for
delivering Flt3 signals to developing DCs in vivo. Hematopoietic-
specific deletion of STAT3 results in acute loss of cDCs and
attenuated responses to Flt3L in vivo (Laouar et al., 2003). Con-
versely, STAT3 overexpression promotes DC maturation from
hematopoietic progenitors (Onai et al., 2006).
DC development is critically regulated by additional transcrip-
tion factors beyond STAT3. IRF8 is required for maturation of
pDCs and CD8a+ DCs (Schiavoni et al., 2002; Tsujimura et al.,
2003), SpiB is necessary for pDCs (Schotte et al., 2004), and
PU.1 is important for cDCs (Anderson et al., 2000; Guerriero
et al., 2000). Flt3 signaling stimulates the expression of PU.1
and STAT3 (Onai et al., 2006), thus reinforcing pathways neces-
sary for DC formation. The mechanisms that dictate specifica-
tion of pDCs and cDCs from the common DC precursor are
unclear yet are likely to involve regulation of transcription-factor
expression or function.
GM-CSF is an important growth factor for cDCs (Daro et al.,
2000; Inaba et al., 1992; Mach et al., 2000; Vremec et al., 1997);
however, it potently inhibits pDC production in Flt3L bone-
marrow cultures (Gilliet et al., 2002). GM-CSF activates several
signaling pathways, including STATs 1, 3, and 5. Here, we show
that GM-CSF utilizes STAT5 to block pDC-related gene expres-
sion and pDC development from lin Flt3+ progenitor cells.
STAT5 directly inhibited transcription of Irf8, which is neces-
sary for pDC development, thereby revealing a mechanism byImmunity 28, 509–520, April 2008 ª2008 Elsevier Inc. 509
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GM-CSF and STAT5 Block pDC DevelopmentFigure 1. Cytokine-Driven DC Differentiation from Lin Flt3+ Bone-Marrow Progenitors
(A) FACS purification of lin Flt3+ cells (lin PDCA1 B220 Flt3+ CD11c) and pDCs (lin PDCA1+ B220+ CD11c+).
(B) Postsorting analysis of purified lin Flt3+ cells and pDCs.
(C) Lin Flt3+ cells were cultured in 100 ng/ml Flt3L, 50 ng/ml GM-CSF, or 100 ng/ml Flt3L plus 50 ng/ml GM-CSF for 7 days and analyzed by flow cytometry for
pDCs (CD11c+ CD11b B220+ or CD11c+ CD11b PDCA1+ cells) and cDCs (CD11c+ CD11b+ cells).
(D) Lin Flt3+ cells were labeled with CFSE, cultured for 3 days, and analyzed by flow cytometry.
(E) pDCs were cultured for 7 days (antibody stain) or 3 days (CFSE stain) prior to analysis.which GM-CSF and STAT5 appear to control pDC lineage fate
decisions within the DC progenitor compartment.
RESULTS
GM-CSF Suppresses Flt3L-Dependent Development
of pDCs from Lin Flt3+ Progenitors
To determine whether GM-CSF inhibited pDC development, we
investigated its activity on lin Flt3+ cells and pDCs. Lin Flt3+
cells and pDCs were isolated from murine bone marrow by mag-
netic bead separation followed by FACS (Figure 1A; data not
shown). Postsorting analysis confirmedR 98% purity in the lin
Flt3+ or CD11c+ CD11b B220+ pDC populations, respectively
(Figure 1B). Lin Flt3+ cells were cultured in Flt3L, GM-CSF, or
Flt3L plus GM-CSF for 7 days; subsequently, pDC and cDC pro-
duction was measured. Flt3L stimulated pDC development,
whereas GM-CSF enhanced cDCs but not pDC maturation (Fig-
ure 1C). The addition of GM-CSF to Flt3L cultures inhibited pDC
development (Figure 1C). Furthermore, GM-CSF plus Flt3L stim-
ulated increased maturation of cDCs relative to Flt3L alone, with510 Immunity 28, 509–520, April 2008 ª2008 Elsevier Inc.cDC frequencies approaching those observed in GM-CSF alone
(Figure 1C). CFSE labeling showed a similar degree of cellular
proliferation in Flt3L and Flt3L-plus-GM-CSF conditions, indicat-
ing that GM-CSF does not affect Flt3L-dependent growth of lin
Flt3+ cells (Figure 1D). Moreover, the majority of the lin Flt3+
population was responsive to GM-CSF as the sole exogenous
growth factor (Figure 1D).
Neither Flt3L nor Flt3L plus GM-CSF induced cellular prolifer-
ation of pDCs (Figure 1E). Flt3L maintained pDCs in culture, and
addition of GM-CSF was incapable of promoting the formation of
cDCs from pDCs (Figure 1E). These results ruled out the possibil-
ity that GM-CSF operated by stimulating further maturation of
pDCs into cDCs. Collectively, our results showed that GM-CSF
acted upon the early lin Flt3+ DC progenitor stage to inhibit
Flt3L-driven pDC development.
Signal Transduction by Flt3L and GM-CSF
in Lin Flt3+ Progenitors and pDCs
To examine the mechanisms involved in GM-CSF-mediated
suppression of pDCs, we tested Flt3L- and GM-CSF-responsive
Immunity
GM-CSF and STAT5 Block pDC DevelopmentFigure 2. Flt3L- and GM-CSF-Responsive STAT Activation and Gene Expression in Lin Flt3+ Cells
(A) Lin Flt3+ cells were incubated without exogenous cytokine for 4 hr, then stimulated with Flt3L (100 ng/ml), GM-CSF (50 ng/ml), or Flt3L (100 ng/ml) and
GM-CSF (50 ng/ml) for 20 min, as indicated. Activated and total STAT protein amounts were determined by immunoblotting.
(B) Lin Flt3+ cells and pDCs were stimulated with Flt3L ± GM-CSF for 30 min. Expression of CIS and GAPDH was determined by RT-PCR.
(C) Lin Flt3+ cells and pDCs were incubated ± GM-CSF for 4 hr, then stimulated with Flt3L or maintained in GM-CSF alone for an additional 20 min. Activated and
total STAT protein amounts were assessed by immunoblotting.
(D) Lin Flt3+ progenitors were stimulated with Flt3L (open circles) or Flt3L and GM-CSF (black circles) for 0, 16, 36, or 72 hr. Gene expression was determined by
quantitative PCR. Error bars represent SD.STAT signal transduction. Lin Flt3+ cells were cultured in cyto-
kine-free conditions for 4 hr to reduce endogenous STAT activity
and were then stimulated with Flt3L, GM-CSF, or Flt3L plus GM-
CSF for 20 min to study immediate signaling responses. Flt3L
activated STAT3 yet did not activate STAT5 at a detectable
amount. GM-CSF alone, or in combination with Flt3L, stimulated
both STAT3 and STAT5 (Figure 2A).
Selective activation of STAT5 by GM-CSF suggested that
STAT5 might induce a negative-feedback pathway to suppress
immediate Flt3-dependent signaling, and thus pDC develop-
ment. Therefore, we measured expression of the STAT5 target
gene cis, which is involved in cytokine negative regulation
(Matsumoto et al., 1997). GM-CSF enhanced CIS expression in
lin Flt3+ cells and pDCs (Figure 2B). Preincubation with GM-
CSF, however, did not affect STAT3 activation by Flt3L in lin
Flt3+ cells or pDCs (Figure 2C). By contrast, activated STAT5
was reduced considerably after pretreatment with GM-CSF
(Figure 2C). This suggested that GM-CSF-responsive negative-
feedback pathways, such as cis, repressed GM-CSF-dependent
STAT5 signaling but did not contribute substantially to inhibition
of pDC development by blocking immediate Flt3L-dependent
STAT3 activation.To assess whether GM-CSF regulated the expression of
receptors with important roles in DCs, we examined Flt3, GM-
CSFRa, and TLR9 mRNA amounts in lin Flt3+ cells stimulated
with Flt3L or Flt3L plus GM-CSF. Flt3 expression declined during
culture in Flt3L alone, and the addition of GM-CSF substantially
accelerated Flt3 repression (Figure 2D). GM-CSFRa expression
was modestly induced by Flt3L and by the combination of Flt3L
plus GM-CSF to similar degrees (Figure 2D). TLR9 expression
was upregulated in Flt3L-stimulated progenitors; however, this
induction was suppressed in the presence of GM-CSF (Fig-
ure 2D). Thus, GM-CSF inhibited the expression of Flt3 and
TLR9, which are important for pDC development and function,
in the developing lin Flt3+ progenitor population.
STAT3 Controls Flt3L-Dependent Proliferation
but Not pDC Differentiation or GM-CSF-Mediated
pDC Suppression
For the testing of STAT3 function, bone-marrow cells from mice
with hematopoietic conditional STAT3 deletion [i.e., Tg(Tek-
cre)12Flv Stat3f/D] were cultured in Flt3L, GM-CSF, or Flt3L plus
GM-CSF and analyzed for proliferation and DC development.
STAT3 was important for Flt3L-dependent growth of total boneImmunity 28, 509–520, April 2008 ª2008 Elsevier Inc. 511
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GM-CSF and STAT5 Block pDC DevelopmentFigure 3. Flt3L- and GM-CSF-Dependent DC Development from STAT3-Deficient Bone-Marrow and Lin Flt3+ Progenitors
(A) From STAT3-deficient [i.e., Tg(Tek-cre)12Flv Stat3f/D] and wild-type (WT) mice, 23 106 bone-marrow cells were cultured in Flt3L, GM-CSF, or Flt3L plus GM-
CSF for 7 days, and cell numbers were determined by enumeration. The data represent mean values ± SD from three independent experiments.
(B) Bone-marrow cells were stained with CFSE, cultured as indicated for 3 days, and analyzed by flow cytometry.
(C and D) Bone-marrow cells were cultured as indicated for 7 days; pDC (CD11c+ CD11b PDCA1+) and cDC (CD11c+ CD11b+) frequencies and absolute num-
bers were determined. Error bars represent SD.
(E) Lin Flt3+ cells were cultured for 7 days; pDC and cDC frequencies were analyzed.
(F) WT and STAT3-deficient pDCs were isolated from fresh bone-marrow samples by FACS, or following ex vivo differentiation in Flt3L (7 days). pDCs
(4 3 104/100 ml) were stimulated with 5 mM CpG-A or left untreated for 24 hr. IFNa production was determined by ELISA.marrow yet was dispensable for GM-CSF- or Flt3L-plus-GM-CSF-
responsive growth (Figure 3A). CFSE labeling confirmed that
STAT3 was crucial for Flt3L-dependent proliferation (Figure 3B).
Flt3L stimulated pDC and cDC development from wild-type
(WT) and STAT3-deficient total bone-marrow samples (Fig-
ure 3C); however, absolute DC numbers were severely reduced
in STAT3-deficient cultures (Figure 3D). Moreover, purified WT
and STAT3-deficient lin Flt3+ progenitors generated pDCs and
cDCs in response to Flt3L (Figure 3E). These data collectively
indicated an important role for STAT3 in Flt3L-mediated DC
progenitor proliferation but not DC lineage commitment.
GM-CSF blocked Flt3L-driven pDC development from WT and
STAT3-deficient bone marrow, as indicated by the reduced pro-
portion and absolute number of pDCs in Flt3L-plus-GM-CSF cul-512 Immunity 28, 509–520, April 2008 ª2008 Elsevier Inc.tures relative to Flt3L alone (Figures 3C and 3D). Flt3L-driven
pDC maturation from lin Flt3+ progenitors was also inhibited
by GM-CSF (Figure 3E). When used as the sole growth factor,
GM-CSF stimulated cDC development yet failed to promote pDC
maturation from WT and STAT3-deficient cells (Figures 3C and
3D). Moreover, addition of GM-CSF to Flt3L cultures rescued
the development of STAT3-deficient cDCs, restoring cDC
numbers similar to those found in WT Flt3L cultures (Figure 3D).
Thus, STAT3 was dispensable for GM-CSF-dependent pDC
suppression and cDC development.
To determine if STAT3 was important for terminal differentia-
tion of pDCs, we examined whether STAT3-deficient pDCs could
respond to CpG stimulation by producing IFN-a. Freshly isolated
bone-marrow pDCs or pDCs derived from Flt3L-stimulated
Immunity
GM-CSF and STAT5 Block pDC DevelopmentFigure 4. Cytokine-Driven DC Development from Stat5+/+ and Stat5/ Fetal Liver Cells
For 7 days 1 3 106 FL (E14.5) cells were cultured in 100 ng/ml Flt3L ± 50 ng/ml GM-CSF.
(A) Total cell number in each culture was determined by enumeration. Error bars represent SD.
(B) pDC (CD11c+ CD11b PDCA1+) and cDC (CD11c+ CD11b+) frequencies are shown.
(C) Absolute numbers of pDCs, cDCs, and CD11c+ CD11b DCs (CD11b DCs) were determined. The data represent mean values ± SD from three independent
experiments.bone-marrow cultures produced similar amounts of IFNa, re-
gardless of STAT3 status (Figure 3F). Taken together, therefore,
our data suggested that STAT3 controls an essential Flt3L-
driven proliferative phase in the DC developmental pathway,
yet STAT3 does not dictate critical specification and maturation
steps in the pDC lineage, or regulation of GM-CSF-dependent
pDC suppression.
STAT5 Is Essential for GM-CSF-Dependent Suppression
of pDC Development from Fetal Liver Progenitor Cells
To test the function of STAT5 in GM-CSF-mediated suppression
of pDC development, we utilized fetal liver (FL) hematopoietic
progenitors from Stat5+/+ and Stat5/ embryos because com-
plete STAT5 deletion causes neonatal lethality (Cui et al., 2004).
We found that Flt3L or Flt3L plus GM-CSF stimulated growth
of Stat5+/+ and Stat5/ FL cells (Figure 4A). In addition, Flt3L
supported pDC maturation from Stat5+/+ and Stat5/ FL cells
(Figure 4B). Thus, STAT5 was dispensable for Flt3L-driven FL
cell proliferation and pDC development.
GM-CSF inhibited Flt3L-driven pDC maturation from Stat5+/+
FL cells (Figures 4B and 4C). Deletion of STAT5, however, en-
abled pDC development in Flt3L plus GM-CSF, as judged by theincreased frequency and absolute number of pDCs in Stat5/
FL cultures relative to Stat5+/+ (Figures 4B and 4C). In addition,
the absolute number of Stat5/ pDCs was similar in Flt3L plus
GM-CSF compared to Flt3L alone (Figure 4C). STAT5 was dis-
pensable for cDC and CD11b DC development in response to
Flt3L or Flt3L plus GM-CSF (Figures 4B and 4C). Culture of
Stat5+/+ FL progenitors in GM-CSF alone failed to promote
pDC development; however, a low frequency of pDCs matured
from Stat5/ progenitors grown in GM-CSF (data not shown).
Thus, STAT5 has a fundamental role in mediating GM-CSF-de-
pendent inhibition of pDC development but not GM-CSF-driven
cDC maturation from FL progenitors ex vivo. Furthermore, the
results suggested GM-CSF-dependent pDC inhibition was
independent of global effects on cellular proliferation.
STAT5 Regulates the Production of pDCs during
Bone-Marrow Reconstitution after Ablative Irradiation
For examination of STAT5 function in vivo, FL progenitors
from Stat5+/+ or Stat5/ embryonic day 14.5 (E14.5) animals
(CD45.2+) were transplanted into lethally irradiated CD45.1+ con-
genic recipients. Chimerism and DC frequencies in the bone
marrow and spleen were analyzed at 8 weeks after transplant.Immunity 28, 509–520, April 2008 ª2008 Elsevier Inc. 513
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GM-CSF and STAT5 Block pDC DevelopmentFigure 5. Development of pDCs and cDCs from Stat5+/+ and Stat5/ Fetal Liver Progenitors In Vivo
(A and D) Left panels: The frequency of donor-derived CD45.2+ cells in the bone marrow or spleen of Stat5+/+ and Stat5/ transplant recipients was determined.
Second column: The percentage of CD11c+ CD11b, CD11c+ CD11b+, and CD11c CD11b+ cells within the bone-marrow or spleen CD45.2+ subset from
Stat5+/+ and Stat5/ recipients is shown. The CD45.2+ CD11c+ CD11b (R1, boxed) and CD45.2+ CD11c+ CD11b+ (R2, boxed) subsets were analyzed for
PDCA1 expression. Third and fourth columns: Frequencies of donor-derived pDCs (CD45.2+ CD11c+ CD11b PDCA1+ cells), cDCs (CD45.2+ CD11c+
CD11b+ cells, which are negative for PDCA1), and CD11b DCs (CD45.2+ CD11c+ CD11b PDCA1) from a representative experiment are shown.
(B and E) Relative frequencies of pDCs, CD11b DCs, and cDCs within the donor-derived CD45.2+ CD11c+ DC population in the bone marrow or spleen of
Stat5+/+ and Stat5/ recipient mice were determined. The data represent individual (open circles) and mean (bar) values for Stat5+/+ or Stat5/ chimeric
mice (n = 8/genotype) from two independent experiments. p values determined by unpaired two-tailed Student’s t test are indicated.
(C) pDCs were recovered from Stat5/ (black bars) and Stat5+/+ (white bars) recipient mice by FACS; cells were stimulated with CpG-A (5 mM), and IFNa
production was measured. The data represent mean values ± SD from two independent experiments.
(F) The donor-derived CD45.2+ population from the spleen of Stat5+/+ and Stat5/ transplant recipient mice was analyzed for CD11chi CD4+ CD11b+, CD11chi
CD8a+, and CD11chi CD8a DC subsets by flow cytometry.Stat5/ FL progenitors repopulated the bone-marrow com-
partment with modestly reduced ability relative to Stat5+/+ pro-
genitors yet showed decreased ability to repopulate the spleen
(Figure 5), consistent with their lymphoid deficiency (Yao et al.,
2006).
Stat5/ FL progenitors contributed to the pDC lineage more
efficiently than Stat5+/+ progenitors, as judged by comparison
of relative pDC frequencies within the donor-derived (i.e.,
CD45.2+ CD11c+) DC subset (Figures 5A and 5B). Stat5/ pDCs
were also present at higher proportions in the total donor-514 Immunity 28, 509–520, April 2008 ª2008 Elsevier Inc.derived bone-marrow compartment, relative to Stat5+/+ pDCs
(Table 1). Although similar absolute pDC numbers were found
in Stat5+/+ and Stat5/ chimeras, the total donor-derived
bone-marrow cell number was reduced in Stat5/ recipients,
indicating an enhanced propensity for Stat5/ progenitors to
generate pDCs (Table 1). Furthermore, we found a decreased
proportion and absolute number of Stat5/ CD11c+ CD11b
PDCA1 DCs (CD11b DCs) within the donor-derived DC
bone-marrow subset, relative to Stat5+/+ recipients (Figures 5A
and 5B). This reduction corresponded to lower bone-marrow
Immunity
GM-CSF and STAT5 Block pDC DevelopmentTable 1. Absolute Number of Donor-Derived Cells
BM
Total (3106) pDCs (3105) CD11b DCs (3105) cDCs (3105)
Stat5+/+ 63.93 ± 7.35 8.80 ± 1.36 2.65 ± 0.56 4.83 ± 0.88
Stat5/ 45.88 ± 20.55 9.05 ± 2.26 1.91 ± 0.76 4.18 ± 0.90
Spleen
Total (3106) pDCs (3105) CD11b DCs (3105) cDCs (3105)
Stat5+/+ 203.04 ± 31.40 17.28 ± 8.51 20.43 ± 3.45 43.86 ± 15.81
Stat5/ 17.05 ± 8.58 7.03 ± 2.18 6.14 ± 3.15 15.79 ± 5.30
Absolute numbers of total donor-derived CD45.2+ cells, donor-derived CD45.2+ pDCs, CD45.2+ CD11b DCs, and CD45.2+ CD11b+ cDCs were
determined within the bone marrow and spleen of Stat5+/+ and Stat5/ transplant recipients. Values reflect the mean ± SD from eight bone-marrow
chimeric mice (two independent experiments).cell numbers in Stat5/ chimeras (Table 1). Similar proportions
and absolute numbers of cDCs were observed in the donor-de-
rived DC subset and total bone-marrow compartment of Stat5+/+
and Stat5/ chimeras (Figures 5A and 5B, Table 1). Overall,
Stat5/ progenitors repopulated the total bone-marrow DC
compartment better than Stat5+/+ progenitors, as judged by an
increased proportion of CD45.2+ CD11c+ cells in Stat5/ recip-
ients (Figure 5A). Importantly, STAT5 was not essential for pDC
functional maturation because equivalent amounts of IFN-
a were produced by pDCs isolated from the bone marrow of
Stat5+/+ and Stat5/ chimeric mice in response to CpG stimula-
tion (Figure 5C).
The relative proportions of DC subsets in the spleen of trans-
plant-recipient animals showed a similar trend to that observed
in the bone marrow. We found increased pDC frequencies, re-
duced CD11b DCs, and similar cDC proportions in the donor-
derived splenic CD45.2+ CD11c+ DC compartment of Stat5/
recipients relative to Stat5+/+ recipients (Figures 5D and 5E). Ex-
amination of the splenic CD11chi population revealed elevated
proportions of CD8a+ DCs and reduced CD4+ CD11b+ DCs in
Stat5/ chimeric mice compared to Stat5+/+ chimeras (Fig-
ure 5F). Splenic cellularity was dramatically decreased in
Stat5/ recipients, leading to a significant reduction in the abso-
lute numbers of splenic pDCs, CD11b DCs, and cDCs relative
to Stat5+/+ recipients (Table 1). The overall proportion of donor-
derived DCs was higher in the spleen of Stat5/ recipients com-
pared to Stat5+/+ recipients (Figure 5D, middle panels), similar to
observations in the bone marrow, and thus supporting the notion
that lymphoid repopulation but not DC repopulation is affected
in Stat5/ recipients. Hence, STAT5 has an important role in
controlling the proportion of pDC and CD11bDC subsets within
the bone marrow and spleen during hematopoietic recon-
stitution following ablative irradiation. In these hematopoietic
tissues, STAT5 repressed pDC development and concomitantly
enhanced CD11b DC formation.
STAT5 Controls GM-CSF-Mediated Suppression
of pDCs from Purified Adult Lin Flt3+ Progenitors
Hematopoietic progenitors from fetal liver and adult bone mar-
row have differences in developmental potential. To determine
whether STAT5 was necessary for GM-CSF-mediated suppres-
sion of pDC development from adult bone-marrow progenitor
cells, we recovered donor-derived lin Flt3+ progenitors (i.e.,
CD45.2+ lin Flt3+ cells) from the bone marrow of Stat5+/+ andStat5/ recipient mice. Lin Flt3+ cells were cultured in the pres-
ence of Flt3L, GM-CSF, or Flt3L plus GM-CSF for 7 days and
were subsequently analyzed for pDC and cDC frequencies.
STAT5 was dispensable for Flt3L-driven pDC development, as
anticipated (Figure 6A). STAT5 function was required, however,
for efficient suppression of Flt3L-driven pDC development by
GM-CSF. An increased proportion of pDCs developed from
Stat5/ lin Flt3+ progenitors in Flt3L plus GM-CSF, relative to
Stat5+/+ progenitors in corresponding culture conditions, ap-
proaching pDC proportions found in Flt3L alone (Figure 6A). In
addition, GM-CSF induced pDCs from Stat5/ lin Flt3+ pro-
genitors but not Stat5+/+ progenitors (Figure 6A), suggesting
that GM-CSF signals are sufficient for pDC maturation in cells
lacking functional STAT5. Thus, STAT5 is necessary for GM-
CSF-mediated pDC suppression from the purified lin Flt3+
progenitor subset.
STAT5 Controls the Expression of Critical DC-Lineage
Transcription Factors
To assess the mechanism of GM-CSF- and STAT5-mediated
suppression of pDCs, donor-derived lin Flt3+ cells from
Stat5+/+ and Stat5/ chimeras were stimulated with Flt3L or
Flt3L plus GM-CSF and examined for the expression of transcrip-
tion factors that are important in DCs, including PU.1, IRF2, IRF4,
IRF7, IRF8, and SpiB (Wu and Liu, 2007; Zenke and Hieronymus,
2006). PU.1 and IRF2 were regulated similarly inStat5+/+ linFlt3+
cells in Flt3L or Flt3L plus GM-CSF (Figure 6B), suggesting that
they are not involved in pDC suppression by GM-CSF and
STAT5. By contrast, IRF4 expression was strongly induced in
Stat5+/+ lin Flt3+ cells in Flt3L plus GM-CSF, relative to Flt3L
alone (Figure 6B). Furthermore, expression of IRF7 and IRF8
was inhibited by GM-CSF plus Flt3L versus Flt3L alone, whereas
SpiB induction was delayed by GM-CSF (Figure 6B). Because
IRF4 is important for cDC development and IRF8, SpiB, and
IRF7 have critical roles in pDCs, our results suggested that
GM-CSF extinguishes a transcriptional network necessary for
pDC development while enhancing pathways that promote
cDC maturation.
STAT5 was dispensable for the expression of each factor in
Flt3L alone (Figure 6C), consistent with Flt3L-driven pDC and
cDC development fromStat5/ progenitors ex vivo and repopu-
lation of the pDC compartment in Stat5/ transplant-recipient
mice (Figures 4, 5, and 6A). By contrast, GM-CSF inhibited the
expression of IRF7, IRF8, and SpiB in lin Flt3+ cells via aImmunity 28, 509–520, April 2008 ª2008 Elsevier Inc. 515
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GM-CSF and STAT5 Block pDC DevelopmentFigure 6. STAT5 Function in DC Development and Gene Expression
Donor-derived CD45.2+ lin Flt3+ progenitor cells were recovered from the bone marrow of Stat5+/+ and Stat5/ transplant recipient mice by FACS.
(A) CD45.2+ lin Flt3+ cells were cultured as indicated for 7 days; pDC (CD11c+ CD11b PDCA1+) and cDC (CD11c+ CD11b+) frequencies were determined.
(B) Stat5+/+ CD45.2+ lin Flt3+ cells were cultured for 0, 16, 36, or 72 hr in Flt3L (solid line, open circles) or Flt3L plus GM-CSF (hatched line, black circles). Real-
time PCR was used to determine transcription-factor mRNA expression. Error bars represent SD.516 Immunity 28, 509–520, April 2008 ª2008 Elsevier Inc.
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GM-CSF and STAT5 Block pDC DevelopmentSTAT5-dependent mechanism, whereas GM-CSF-dependent
induction of IRF4 was attenuated in Stat5/ lin Flt3+ cells
(Figure 6C). These results point to an essential role for STAT5 in
mediating the effects of GM-CSF upon the DC transcriptional
network in developing lin Flt3+ bone-marrow progenitor cells.
STAT5 Directly Suppresses IRF8 Expression
by a Mechanism Involving STAT5 Recruitment
at the Irf8 Promoter
The Irf4 and Irf8 promoters contain STAT consensus sites (Kanno
et al., 1993; Matsuyama et al., 1995); however, the SpiB pro-
moter lacks STAT consensus sites within its proximal 2 kb re-
gion, as judged by nucleotide-sequence analysis (not shown).
We therefore focused on STAT5 regulation of IRF4 and IRF8.
We found that GM-CSF-mediated downregulation of IRF8 was
recapitulated in the murine splenic DC line D2SC/1 (Granucci
et al., 1994), whereas induction of IRF4 by GM-CSF was not ob-
served by 2 hr stimulation (Figure 6D). These results suggested
that IRF8 but not IRF4 was a direct target of the GM-CSF and
STAT5 pathway, and they indicated that D2SC/1 cells provide
a model system for investigation of IRF8 regulation by STAT5.
We found that GM-CSF suppressed reporter activity of an Irf8
promoter construct, consistent with its activity on endogenous
IRF8 expression (Figure 6F). EMSAs showed that GM-CSF stim-
ulated DNA binding to a STAT consensus site in the Irf8promoter,
previously shown to be IFN responsive (Kanno et al., 1993).
STAT5 interacted specifically with this STAT site, as judged by
STAT5 antibody supershifts and competition with a STAT5 con-
sensus oligonucleotide (Figure 6E). Chromatin immunoprecipita-
tion experiments showed that STAT5 was recruited to the pro-
ximal Irf8 promoter upon GM-CSF stimulation but was not
detectable at the Irf4 promoter (Figure 6G). Thus, GM-CSF stim-
ulated STAT5 interaction at the endogenous Irf8 promoter to
inhibit IRF8 expression, indicating a direct mechanism of IRF8
regulation by GM-CSF-dependent STAT5 signaling.
DISCUSSION
STAT proteins have a central role in blood cell production in
steady-state conditions and physiological stress situations
such as infection. Distinct DC subsets reside throughout the
body, yet the basic mechanisms that control DC development
by cytokines and STATs remain relatively elusive. The Flt3L-de-
pendent STAT3 signaling pathway has emerged as a major reg-
ulator of DC production in vivo (Karsunky et al., 2003; Laouar
et al., 2003; Maraskovsky et al., 1996; Pulendran et al., 2000).
In agreement, we found that STAT3 was necessary for prolifera-
tion of bone-marrow progenitors to Flt3L, and absolute pDC andcDC numbers were reduced in STAT3-deficient bone-marrow
cultures as a consequence. STAT3 was dispensable for pDC
specification and maturation, however, because STAT3-defi-
cient pDCs responded to CpG stimulation by producing IFN-a,
a hallmark of differentiated pDCs. Our data support the idea
that STAT3 regulates the proliferation and/or maintenance of the
Flt3+ progenitor population and thereby controls absolute pro-
duction of DCs (Laouar et al., 2003), yet STAT3 is not essential
for the commitment or development of the pDC lineage.
GM-CSF and STAT5 override Flt3L-dependent signals in early
stages of the pDC developmental pathway to block pDC
commitment and/or terminal maturation. This was shown by
GM-CSF- and STAT5-mediated inhibition of absolute pDC pro-
duction in ex vivo FL cultures and selective blockade of pDC
maturation from purified lin Flt3+ bone-marrow progenitors.
GM-CSF was unable to induce the conversion or maturation of
pDCs to cDCs, underscoring the idea that it operates early in
pDC development. GM-CSF may act on the common DC progen-
itor within the adult lin Flt3+ bone-marrow subset (Onai et al.,
2007) to suppress pDC lineage commitment and/or maturation
while concomitantly supporting or enhancing cDC specification.
The DC progenitor population is less characterized during fetal
development, yet we show that development of FL pDCs are in-
hibited by GM-CSF and STAT5, indicating the possibility of an
equivalent to the adult common DC progenitor in FL. Moreover,
because both FL progenitors and adult lin Flt3+ bone-marrow
cells responded to the inhibitory actions of GM-CSF and STAT5,
this pathway may be important in regulating pDC abundance
during ontogeny.
pDC repopulation after bone-marrow ablation was negatively
regulated by STAT5, suggesting that the DC progenitor compart-
ment may respond to STAT5-activating cytokines to control bal-
anced production of the DC lineages in vivo. By contrast, STAT5
was unnecessary for repopulation of cDCs, consistent with the
fact that GM-CSF appears to be largely dispensable for cDC
maturation in vivo (Vremec et al., 1997). In ex vivo conditions,
however, STAT5 was important for GM-CSF-driven cDC devel-
opment from lin Flt3+ progenitors. It remains to be determined
whether cDC development in vivo is regulated by other cytokines
beyond Flt3L; our results suggest that STAT5-acting cytokines
may have some ability to control cDC production from bone
marrow, yet this pathway would be redundant or secondary to
Flt3L and STAT3. For pDCs, additional studies should assess
the function of other STAT5-activating cytokines, or endogenous
and pharmacological amounts of GM-CSF in steady-state and
‘‘emergency’’ conditions such as infection, to determine whether
they repress pDC maturation in vivo. Modulation of pDCs by
STAT5-acting cytokines may influence the outcome of immune(C) CD45.2+ lin Flt3+ cells from Stat5+/+ and Stat5/ recipient mice were cultured in Flt3L (white bars) or Flt3L plus GM-CSF (black bars) for 36 hr. Transcription-
factor mRNA expression was determined by real-time PCR. Error bars represent SD.
(D) D2SC/1 cells were stimulated with GM-CSF or left untreated for 120 min; expression of IRF4 and IRF8 mRNA was measured by real-time PCR. Error bars
represent SD.
(E) D2SC/1 cells stably expressing STAT5a were stimulated with GM-CSF or left untreated for 30 min. Nuclear extracts were recovered and used in EMSAs with or
without STAT5 supershift antibody or competitor oligonucleotides (D, Irf8 STAT site; mD, mutated Irf8 STAT site; S5, b-casein STAT site; P, Irf8 STAT-like site).
GM-CSF-responsive STAT5 DNA binding and STAT5 antibody supershift complexes are indicated (open and closed stars, respectively).
(F) Luciferase assays were performed as described in the Experimental Procedures. Error bars represent SD.
(G) D2SC/1 cells were stimulated with GM-CSF for 60 min or left untreated. Chromatin immunoprecipitations were performed with STAT5 antibodies (STAT5) or
an irrelevant IgG (IgG). PCR reactions were performed, with primers specific for the murine Irf4 and Irf8 promoters, on total cell lysates (input) or immunoprecip-
itation samples, as indicated. PCR reactions were visualized by ethidium-bromide staining of agarose gels.Immunity 28, 509–520, April 2008 ª2008 Elsevier Inc. 517
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proach to regulate the abundance of this important cell lineage.
Signaling via Flt3L rapidly induced the expression of key pDC
genes in lin Flt3+ progenitors, including PU.1, IRF7, IRF8, SpiB,
and TLR9. It is notable that this group includes three transcrip-
tion factors with clear roles in pDC lineage specification or
maturation (i.e., PU.1, IRF8, and SpiB) (Anderson et al., 2000;
Guerriero et al., 2000; Schiavoni et al., 2002; Schotte et al.,
2004; Tsujimura et al., 2003), suggesting that Flt3L may initiate
and/or sustain the transcriptional network required for pDC de-
velopment. Others have shown a limited instructive function for
STAT3 in redirecting megakaryocyte-erythroid progenitors
(MEPs) to a pDC and cDC fate (Onai et al., 2006), although it is
not yet known whether STAT3 directly or indirectly controls
Flt3L-mediated DC gene expression. Furthermore, STAT3-inde-
pendent commitment and maturation pathways also exist for the
pDC lineage because functional pDCs mature from STAT3-defi-
cient bone-marrow progenitors. The collective data suggest that
STAT3 supports and/or reinforces Flt3L-mediated execution of
the pDC developmental program, presumably in a permissive
environment, in which pDC-related genes are accessible to the
transcriptional machinery.
STAT5 inhibited the propensity of bone-marrow progenitors to
generate pDCs in vivo, indicating that it could affect DC lineage
fate decisions. These results are reminiscent of the lymphoid to
myeloid lineage-conversion function for GM-CSF in CLPs and
early T cell progenitors (Iwasaki-Arai et al., 2003; Kondo et al.,
2000) and of IL-2- and STAT5-mediated inhibition of Th17 devel-
opment (Laurence et al., 2007), a process that is dependent upon
STAT3 and STAT3-activating cytokines (Nurieva et al., 2007;
Yang et al., 2007). Molecularly, GM-CSF and STAT5 appeared
to exert a broad effect on the DC transcriptional network in lin
Flt3+ progenitors by overriding Flt3L-mediated induction and/
or reinforcement of pDC-related gene expression; to suppress
Flt3, TLR9, IRF7, IRF8, and SpiB; and to induce IRF4, a key factor
in cDC development (Suzuki et al., 2004; Tamura et al., 2005).
Promoter-sequence analysis initially suggested Irf8 and Irf4 as
the most likely direct targets of GM-CSF-dependent STAT5 sig-
naling, and between these two genes only Irf8 appears to be reg-
ulated directly by GM-CSF-activated STAT5. Given that IRF8 is
crucial for pDC maturation (Schiavoni et al., 2002; Tsujimura
et al., 2003), inhibition of its expression by GM-CSF-dependent
STAT5 signaling indicates that this is an essential step in sup-
pressing pDC production. Blockade of IRF8 expression may
negatively affect the expression of regulatory transcription fac-
tors (e.g., SpiB and IRF7) and receptors (e.g., Flt3 and TLR9)
that are necessary for pDC development and function. Further-
more, STAT5-dependent inhibition of IRF8 may lead to the in-
duction of IRF4 and a concomitant activation or reinforcement
of the pathways that control cDC development. Interestingly,
our analysis of splenic DC subsets showed that Stat5/ chime-
ric mice have elevated proportions of CD8a+ DCs and reduced
CD4+ CD11b+ DCs within the CD11chi population, compared
to Stat5+/+ chimeras. IRF8 is essential for the development of
CD8a + DCs, whereas IRF4 is important for formation of the
splenic CD4+ CD11b+ DC subset (Schiavoni et al., 2002; Suzuki
et al., 2004). Thus, the control of IRF4 and IRF8 expression by
GM-CSF-dependent STAT5 signals might factor in the regulation
of these DC subsets in vivo. It is not yet known whether GM-CSF-518 Immunity 28, 509–520, April 2008 ª2008 Elsevier Inc.dependent STAT5-mediated suppression of IRF8 operates in
other hematopoietic lineages to regulate their development
and/or function, although our preliminary studies with the
D2SC/1 (DC) and J774 (macrophage) cell lines suggested this
pathway may be restricted to DCs (data not shown). To under-
stand the molecular pathways by which GM-CSF regulates DC
production from bone-marrow precursors, the direct target
genes of STAT5 and IRF8 must be characterized in linFlt3+ cells.
In summary, we show an essential function for GM-CSF and
STAT5 in controlling the transcriptional program in lin Flt3+ pro-
genitors required for development of the pDC lineage. These re-
sults have important implications: GM-CSF is naturally induced
during infection, and this property is exploited clinically to treat
myelosuppression. Are pDCs adversely affected in these situa-
tions, and how does this impact the immune response? Of equal
importance, can the function of GM-CSF be harnessed to treat
conditions, such as psoriasis, that are associated with pDC over-
production or provide an effective approach to modulate DCs in
cancer therapy? The answers to these questions lie in develop-
ing a further understanding of the DC developmental pathway
and the molecular machinery that controls DC lineage fate deci-
sions and functional maturation. Ultimately, this knowledge may
assist in redirecting the immune response to treat immunological
disease and cancer.
EXPERIMENTAL PROCEDURES
STAT-Deficient Mice and Isolation of Bone Marrow and Spleen
Bone-marrow STAT3-deficient mice, which carry the Tek-cre12Flv transgene,
one floxed Stat3 allele, and one deleted Stat3 allele [i.e., Tg(Tek-cre)12Flv
Stat3f/D], were obtained by breeding Tg(Tek-cre)12Flv transgenic and floxed
Stat3 mice as described (Panopoulos et al., 2006). Stat5+/ mice with targeted
disruption of Stat5a and Stat5b (Cui et al., 2004) were intercrossed; E14.5
fetuses were obtained for FL cell isolation. Animals were housed in specific
pathogen-free barrier facilities. All experiments were performed according to
institutional guidelines at UT MD Anderson Cancer Center.
Antibody Staining and Flow Cytometry, CFSE Staining, and Isolation
of Lin Flt3+ Progenitors and pDCs
Single-cell suspensions of bone marrow and spleen were labeled with anti-
bodies (see figure legends) and analyzed on a FACS-Calibur machine. CFSE
labeling was performed according to the manufacturer’s protocol (Invitrogen).
Lin Flt3+ progenitors and pDCs were isolated from total bone marrow by
magnetic bead separation followed by FACS. Negative immunoselection of
lin bone-marrow progenitors was performed with biotin-CD3, biotin-CD11b,
biotin-CD19, and biotin-Ter119 Abs, followed by SA-coated micro beads
(Miltenyi Biotec). Lin PDCA1 B220 Flt3+ CD11c cells (lin Flt3+ progeni-
tors) and lin B220+ CD11c+ cells (pDCs) were isolated on a FACS Aria ma-
chine (BD Biosciences) with FITC-PDCA1, FITC-B220, PE-Flt3, APC-CD11c,
and a mixture of PerCP-Cy5.5-labeled mAbs against lineage markers CD3,
CD11b, and CD19.
In Vitro Culture of Lin Flt3+ Progenitors and pDCs,
and Immunoblot Analysis
Lin Flt3+ progenitors and pDCs were cultured in RPMI 1640 medium contain-
ing 10% FCS, 1 mM sodium pyruvate, HEPES, penicillin, streptomycin and
b-mercaptoethanol (RPMI/FCS) supplemented with murine Flt3L (100 ng/ml),
and/or GM-CSF (50 ng/ml) (R&D Systems), or lacking exogenous cytokine, as
described in the figure legends. Cells were recovered at the indicated time
points for RNA or whole-cell lysate preparation. Immunoblots of whole-cell
lysates were performed with phospho-STAT3 Ab (Cell Signaling), STAT3
(C-20, Santa Cruz), phospho-STAT5 Ab (Cell Signaling), and STAT5 Ab (Santa
Cruz). Enhanced chemiluminescence was used for detection.
Immunity
GM-CSF and STAT5 Block pDC DevelopmentIn Vivo Reconstitution Assays and Isolation of Donor-Derived Cells
Congenic CD45.1+ mice were lethally irradiated (950 rad) and injected intrave-
nously with single-cell suspensions containing 23106 fetal liver cells (CD45.2+)
from E14.5Stat5+/+ orStat5/ embryos and 23 105 host (CD45.1+) bone-mar-
row cells; the latter were used to provide radioprotection. After 8 weeks, mice
were sacrificed, and donor-derived cells (CD45.2+) in bone marrow and spleen
were analyzed by flow cytometry.
For isolation of donor-derived lin Flt3+ progenitors, lin cells were obtained
from bone marrow by negative immunoselection with a mixture of rat mAbs
against the lineage markers CD3, CD11b, CD11c, CD19, and Ter119, followed
by anti-rat IgG-coated micro beads (Miltenyi Biotec). Subsequently, lin
PDCA1 B220 Flt3+ CD45.2+ cells were isolated on a FACS Aria machine
(BD Biosciences) with FITC-PDCA1, FITC-B220, PE-Flt3, PerCP-Cy5.5-
CD45.2, and a mixture of APC-labeled mAbs against lineage markers CD3,
CD11b, CD11c, and CD19.
RNA Isolation andReverse-Transcription andReal-TimePCRAssays
Total RNA was extracted (QIAGEN RNeasy mini protocol) and reverse-tran-
scribed with oligo-dT, random hexamers, and SuperScript RT II (Invitrogen).
Semiquantitative reverse-transcription PCR (RT-PCR) was performed with
previously described primers for CIS and GAPDH (Shigematsu et al., 2004).
Real-time PCR for Flt3, GM-CSFRa, TLR9, PU.1, IRF2, IRF4, IRF7, IRF8,
SpiB, and RPL13A was performed with Power SYBR Green PCR Master Mix
reagent (Applied Biosystems) and a sequence detector (ABI PRISM 7500)
(primer sequences are available upon request). Threshold cycle (CT) values for
each gene were normalized to RPL13A with the Equation 1.8 (RPL13A-GENE)
(100,000), as recommended by the manufacturer, where RPL13A was the
mean CT of duplicate RPL13A runs, GENE was the mean CT of duplicate runs
of the gene of interest, and 100,000 was an arbitrarily chosen factor to bring all
values above zero.
D2SC/1 Cell Culture, Retroviral Infection, Chromatin
Immunoprecipitations, EMSAs, and Reporter Assays
The murine splenic DC cell line D2SC/1 (Granucci et al., 1994) was maintained
in Iscove’s modified Dulbecco’s medium containing 10% heat-inactivated
fetal calf serum and 1% penicillin-streptomycin (Invitrogen-GIBCO). D2SC/1
cells were infected with the bicistronic vector pMIG carrying STAT5 or were
mock infected; after 2–3 days of growth, GFP+ cells were isolated by FACS.
Cells were stimulated with recombinant murine GM-CSF (50 ng/mL) as indi-
cated in the figure legends. Chromatin immunoprecipitation (ChIP) experi-
ments were performed with a mixture of antibodies for STAT5A and STAT5B
(R&D Systems; Santa Cruz), following the recommendation of the manufac-
turer of the ChIP reagents (Upstate Biotechnology). Nuclear extracts (10 mg)
were used in EMSAs with 32P-labeled oligonucleotides corresponding to the
STAT consensus site in the murine Irf8 promoter (Kanno et al., 1993) or bovine
b-casein promoter (Santa Cruz Biotechnology), in the absence or presence of
competitor oligonucleotide or STAT5 antibody, as described (Onishi et al.,
1998). For reporter assays, an Irf8 promoter fragment (351 to +52) was
cloned into pGL4.12 (Promega). D2SC/1 cells were transiently transfected
with pGL4.12 (351 to +52), pME18S-STAT5a, and phRL-TK (Promega) via
Lipofectamine2000 (Invitrogen). After 32 hr, cells were stimulated for 2 hr
with GM-CSF or left untreated. Luciferase activity was measured with the
Dual-Luciferase Reporter Assay System.
Statistical Analysis
Data are presented as mean values ± one standard deviation (SD); p values
were calculated with an unpaired two-tailed Student’s t test.
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